THX Pharma Société Anonyme (EPA:ALTHX)
France flag France · Delayed Price · Currency is EUR
4.275
-0.025 (-0.58%)
Aug 3, 2026, 1:59 PM CET

EPA:ALTHX Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
4.124.777.687.138.28
Depreciation & Amortization Expenses
0.110.10.260.331.2
Other Operating Expenses
-0.18-2.24-0.29-1.210.03
Total Operating Expenses
4.052.637.646.269.51
Operating Income
-4.05-2.63-7.64-6.26-9.51
Interest Income
0.150.10.1200.01
Interest Expense
-0.1-0.07-0.08-0.09-0.11
Other Non-Operating Income (Expense)
00.06-0.03-0.85-0.29
Total Non-Operating Income (Expense)
0.050.090.01-0.93-0.4
Pretax Income
-4-2.53-7.63-7.19-9.91
Provision for Income Taxes
-1-0.77-0.8-0.62-1.76
Net Income
-3-1.77-6.83-6.57-8.15
Net Income to Common
-3-1.77-6.83-6.57-8.15
Net Income Growth
-----
Shares Outstanding (Basic)
149855
Shares Outstanding (Diluted)
149855
Shares Change
61.18%10.03%45.32%6.12%22.70%
EPS (Basic)
-0.22-0.21-0.88-1.23-1.62
EPS (Diluted)
-0.22-0.21-0.88-1.23-1.62
EPS Growth
-----
Free Cash Flow
-0.88-3.37-6.41-5.41-6.16
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.06-0.39-0.83-1.01-1.22
EBITDA
-3.94-2.53-7.39-5.93-8.35
EBIT
-4.05-2.63-7.64-6.26-9.51
Effective Tax Rate
24.95%30.32%10.51%8.63%17.75%